Abstract: A system and method are provided for spectral shaping of light from a broadband source using a linear spatial light modulator (SLM). The system includes an illumination source generating light including a plurality of wavelengths, a lens to collimate the light and an aperture to define its angular spread, a diffraction grating to disperse the beam by wavelength, and a focusing element to focus the dispersed beams from the diffraction grating onto a plurality of pixels of the SLM. The SLM is configured to individually modulate the dispersed beams by diffracting light output therefrom into higher orders, where a diffraction angle of output light is greater than an input cone angle of incoming light from the illumination source.

Abstract: An airbag device configured to be disposed in front of an occupant in a vehicle includes: an inflator configured to generate gas; an airbag that is folded and housed, the airbag being configured to be inflated and deployed by the gas generated by the inflator; and a holding member including an attachment portion to which the inflator is attached, and holding the folded airbag capable of being inflated and deployed from an occupant side opposite the attachment portion. The holding member includes an inhibiting portion that covers a part of the folded airbag from the occupant side and that is configured to partially inhibit initial inflation and deployment of the airbag. The inhibiting portion has a first region and a second region where inhibiting forces that inhibit the initial inflation and deployment are different from each other.

Abstract: Objects are to provide: a fusion protein capable of binding to lipid droplets while having an enzymatic activity to synthesize a hydrophobic compound; a method for producing a substance including accumulating a hydrophobic compound in lipid droplets using the fusion protein; a vector which can enhance production of a hydrophobic compound when it is introduced into cells using genetic recombination techniques; and a transgenic cell into which the vector or a gene coding for the fusion protein has been introduced. The present disclosure relates to a fusion protein having an amino acid sequence (first amino acid sequence) capable of binding to lipid droplets, and an amino acid sequence (second amino acid sequence) having an enzymatic activity to synthesize a hydrophobic compound, with the enzymatic activity of the second amino acid sequence being maintained.

Abstract: The present invention provides a compound represented by Formula (I) or a salt thereof; an LSD1 inhibitor that contains the compound or a salt thereof as an active ingredient; a pharmaceutical composition that contains the compound or a salt thereof; and an antitumor agent that contains the compound or a salt thereof as an active ingredient.

Abstract: A blade includes: an airfoil portion having a pressure surface and a suction surface each of which extends between a base end and a tip end along a blade height direction between a leading edge and a trailing edge; and an internal passage passing through an inside of the airfoil portion, the internal passage having a first opening end opening to one of the pressure surface or the suction surface and a second opening end which is positioned closer to the tip end than the first opening end in the blade height direction and opening to a surface of the airfoil portion. When L is a length from the base end to the tip end in the blade height direction, a distance from the base end to the first opening end in the blade height direction is not less than zero and not greater than 0.3 L.

Abstract: Provided is an easy-to-process thermoelectric conversion device whose shape can be freely changed. The device is provided containing electrodes and an ionic solid, wherein the ionic solid has: an anionic heterometal complex aggregated to form a crystal lattice; and a cationic species present in interstices of the crystal lattice, and wherein the anionic heterometal complex includes: a metal M1 selected from the group consisting of the elements of Groups 8, 9 and 10 of the Periodic Table and Cr and Mn; a metal M2 selected from the group consisting of the elements of Groups 11 and 12 of the Periodic Table; and a ligand.

Abstract: A variable stator vane includes: a stator vane body which includes a radial end surface forming a clearance between the radial end surface and an outer peripheral surface of an inner casing; a rotation shaft which is rotatable so that an angle of the stator vane body with respect to a flow direction of a main stream of a working fluid is varied and which is connected to the radial end surface; and a curved surface portion which is formed on a vane surface adjacent to the radial end surface protruding radially outward from a circumference of the rotation shaft. A curvature radius of the curved surface portion is gradually decreased with distance away from the rotation shaft.

Abstract: The present invention provides a compound represented by Formula (I) or a salt thereof; an LSD1 inhibitor that contains the compound or a salt thereof as an active ingredient; a pharmaceutical composition that contains the compound or a salt thereof; and an antitumor agent that contains the compound or a salt thereof as an active ingredient.

Abstract: A medical information processing apparatus of an embodiment includes an image acquiring unit, an event acquiring unit, a managing unit, and an output unit. The image acquiring unit sequentially acquires medical images during a treatment procedure for a subject. The event acquiring unit sequentially acquires events in the treatment procedure on the basis of the medical images during the treatment procedure. The managing unit manages the medical images and the events, in association with temporal information on the treatment procedure. The output unit outputs the medical images such that relations between the medical images and the events are able to be known.

Abstract: Provided is a method for producing a polyisoprenoid, which can increase natural rubber production by enhancing the rubber synthesis activity of rubber particles. The present invention provides methods for producing a polyisoprenoid using a gene coding for a cis-prenyltransferase (CPT) family protein, a gene coding for a Nogo-B receptor (NgBR) family protein and a gene coding for a rubber elongation factor (REF) family protein, specifically a method for producing a polyisoprenoid in vitro using rubber particles bound to proteins coded for by these genes, and a method for producing a polyisoprenoid in vivo using a recombinant organism (plant) having these genes introduced therein.

Abstract: A coreless motor includes a rotating shaft, a rotor plate attached to the rotating shaft, and a coil supported by the rotor plate. The coil includes a carbon nanotube electric wire, the carbon nanotube electric wire including a carbon nanotube wire and a coating layer, the carbon nanotube wire including a plurality of carbon nanotubes, the coating layer including an insulating layer that covers the carbon nanotube wire so as to insulate the carbon nanotube wire.

Abstract: To provide a connected structure of a substrate and an electric wire with high connection reliability even when a carbon nanotube wire with an average diameter of 0.05 mm to 3.00 mm is used as the electric wire. The connected structure of the substrate and the carbon nanotube wire includes a substrate; a carbon nanotube wire made of one or more carbon nanotube aggregates each including a plurality of carbon nanotubes, the carbon nanotube wire having an average diameter of 0.05 mm to 3.00 mm; a conductive fixing member, part of which is provided between the substrate and the carbon nanotube wire; and a conductive member that electrically connects the carbon nanotube wire and the fixing member.

Abstract: The present invention aims to provide a method for producing a trans-polyisoprenoid which can increase trans rubber production. The present invention is directed to a method for producing a trans-polyisoprenoid in vitro, which involves the use of a gene coding for a trans-prenyltransferase (tPT) family protein and further involves the use of rubber particles bound to a protein encoded by the gene, or a method for producing a trans-polyisoprenoid, which includes introducing into a plant a vector including a promotor having a promoter activity that drives laticifer-specific gene expression and a gene coding for a tPT family protein linked to the promotor to express a protein encoded by the gene specifically in laticifers.

Abstract: When a contact area with a chain guide is reduced to a small area by forming a back surface of a link plate into a convex portion having a round shape or the like, a friction coefficient in a fluid lubrication region is reduced (region E). A coating film containing 10% or more of chromium is formed on the link plate. A friction modifier made of a molybdenum compound such as MoDTC and added to a lubricating oil promotes generation of MoS2 by the chromium coating film, and prevents an increase in the friction coefficient in a boundary lubrication region.

Abstract: The present invention provides a factor capable of predicting an effect of a medicinal therapy on a cancer such as HER2 positive cancer. More specifically, the present invention provides a method of predicting the effect of the medicinal therapy on the cancer, comprising: (1) analyzing a methylation level of a cytosine residue in one or more CpG sites present within a nucleotide sequence in a promotor region, an untranslated region or a translated region of HSD17B4 gene in a sample taken from a human subject; and (2) predicting the effect of the medicinal therapy on the cancer based on the analyzed methylation level.

Abstract: The present invention aims to provide a method for producing a trans-polyisoprenoid which can increase trans rubber production. The present invention is directed to a method for producing a trans-polyisoprenoid in vitro, which involves the use of a gene coding for a trans-prenyltransferase (tPT) family protein and further involves the use of rubber particles bound to a protein encoded by the gene, or a method for producing a trans-polyisoprenoid, which includes introducing into a plant a vector including a promotor having a promoter activity that drives laticifer-specific gene expression and a gene coding for a tPT family protein linked to the promotor to express a protein encoded by the gene specifically in laticifers.

Abstract: According one embodiment, a servo write method includes a head and a disk having a plurality of spiral servo patterns which are written radially in a first direction from a first area to a second area other than the first area at velocity that varies between the first area and the second area, the method including moving the head in a second direction opposite to the first direction to read each of the spiral servo patterns, measuring a plurality of time intervals at which each of the spiral servo patterns is read in the first area, and writing a plurality of servo patterns to the first area based on the time intervals.

Abstract: According to one embodiment, a servo write method includes a head and a disk having a plurality of spiral servo patterns which are written radially in a first direction from a first area to a second area other than the first area at velocity that varies between the first area and the second area, the method including moving the head in a second direction opposite to the first direction to read each of the spiral servo patterns, measuring a plurality of time intervals at which each of the spiral servo patterns is read in the first area, and writing a plurality of servo patterns to the first area based on the time intervals.

Abstract: Provided is a coil device capable of improving operability or durability thereof, being attached to a subject in a close contact state regardless of the size of a head of the subject, and obtaining a high-quality MRI image. The coil device includes at least one coil unit which has a coil element and a coil support portion which has a mechanism for attaching the coil unit to a head of a subject. The coil support portion includes a base portion, a support body which is connected to the base portion and has an elastic member, and a holder which connects the support body to the at least one coil unit and the holder has at least three contact points which are formed directly or indirectly with respect to the base portion.

Abstract: The present invention provides a compound represented by Formula (I) or a salt thereof; an LSD1 inhibitor that contains the compound or a salt thereof as an active ingredient; a pharmaceutical composition that contains the compound or a salt thereof; and an antitumor agent that contains the compound or a salt thereof as an active ingredient.